Heart Failure Diagnosis and Management in Primary Care Dr David Ebbs GP, Didcot Health Centre GPwSI Heart Failure, OxonPCT.

Slides:



Advertisements
Similar presentations
The Balance of Care Group Alternatives to Hospital MODELS OF INTEGRATED CARE Tom Bowen ORAHS 2008, Toronto, 29 July.
Advertisements

The prevalence of use of beta- blockers in secondary prevention of myocardial infarctions in patients hospitalized 1 Institute of Epidemiology and biostatistics,
Ten years of the CHD NSF Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health.
UNDP RBA MDG-Based National Planning Workshop
1 Making Health Care More Affordable: A Bipartisan Reform Agenda Around Chronic Disease Prevention and Management Kenneth E. Thorpe Emory University and.
Multinational Comparisons of Health Systems Data, 2008 Support for this research was provided by The Commonwealth Fund. The views presented here are those.
Diabetes Overview Managing Diabetes in Primary Care.
Echocardiography in CHD Strat Liddiard. CHD NSF Standard 11 nDoctors should arrange for people with suspected heart failure to be offered the appropriate.
Atrial Fibrillation Cardiovascular ISCEE 26th October 2010.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the UK – 30 years on… Since 1981: 122,000 HIV diagnoses.
Advance Heart Failure Therapy
PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham HIP for CHD Jane Matthews Practice Nurse Dr. Dai Evans PRIMIS Regional Clinical Adviser.
Long Distance Titration of Heart Failure Medications by Telephone Calls Anne E. Steckler, RN, Heba Wassif, MD, Kalkidan Bishu, MD, Gardar Sigurdsson, MD,
2003 CDA Clinical Practice Guidelines
Karen Cradock, B. Physio, MSc. Therapy Lead
Jeannie Hayhurst Cardiovascular Specialist Nurse.
Associations between Kidney Function and Subclinical Cardiac Abnormalities in CKD Park M et al. JASN September 2012 Renal Journal Club Oct 2012 BHH Matthew.
Using Prognosis to Make Screening Decisions Elizabeth Eckstrom, MD, MPH Oregon Health & Science University Hollis Day, MD, MS University of Pittsburgh.
1 Lincolnshire Research Observatory Lincolnshire’s Changing Population Components of Change and the Demographic Impact Eleanor.
Nurse Led Clinics Opportunity for nurses to make a difference Wilma Scholte op Reimer, RN, PhD Amsterdam School of Health Professions Academic Medical.
Managing anticoagulation in atrial fibrillation Dr Katy Rice June 2011.
1 GRASP-AF Audit - Intro 8 th July 2010 Mark Gregory.
Di Riley Associate Director, Clinical Outcomes NCIN
September 29,2010 Karen Harkness RN CCNC PhD. Definition Not a clinical diagnosis Heart failure is a complex syndrome in which abnormal heart function.
PSA: Fact or Fiction The debate as it stands
Presentation title: 32pt Arial Regular, black Recommended maximum length: 1 line International efforts to improve quality, reduce costs and increase transparency.
Greenspace and Wellbeing event 13 February 2008 Dr William Bird Strategic Health Advisor Natural England.
Delivering Evidence Based Heart Failure Care Jane Dudley Heart Failure Specialist Nurse.
Are NHS Stop Smoking Services being accessed fairly in Gateshead? Andy Billett, Public Health Analyst NHS South of Tyne and Wear.
Management of Atrial Fibrillation in Primary Care Dr Matthew Fay Westcliffe Medical Practice Shipley Westcliffe Cardiology Service.
Osteoporosis 9 th January 2013 Dr Julian Tomkinson.
SHAHKUR SHABIR GP REGISTRAR DR ELLA RUSSELL -GP TRAINER SUNNYBANK MEDICAL CENTRE OCT 2011.
Bowel Cancer screening programme The Facts Third most common Cancer in the UK. The Second most common cause of cancer deaths in the UK (approx 16,100.
National Service Frameworks Dr Stephen Newell February 2002.
DIABETES AND THE EYE: WHAT YOU SHOULD KNOW ABOUT IT
The Impact of Obesity and the Value of Treatment
HIV and Aging Kathleen K Casey, MD Director, AIDS Ambulatory Care Center Jersey Shore University Medical Center.
When, how and which patient to treat with HBV infection. David Mutimer Queen Elizabeth Hospital Birmingham, England. BSG Post-graduate Course March 20.
Alcohol Medical Scholars Program Alcohol and Women ♀ Nioaka N. Campbell, MD University of South Carolina School of Medicine.
Dementia IGHC Tatiana Kuznetsova, Jan A. Staessen University of Leuven, Belgium Diagnostic criteria for subclinical systolic and diastolic LV function.
Perioperative Management of Heart Failure Gamal Fouad S Zaki, MD Professor of Anesthesiology Ain Shams University
CMS Core Measures Evidence-Based Performance Measurement.
Nabeela Bari Savitha Pushparajah GP respiratory leads.
Alcohol-Related Harm and Unmet Need Amongst Older Drinkers S Wadd, R Driver, D Forrester.
1 Key points – Heart Failure within Bradford 2011.
Dr Catherine Taylor GPST2 Familial Hypercholesterolaemia.
Dorset Improving Diagnosis of Heart Failure Implementation of BNP Measuring in General Practice Ist Project Steering Group 13 th Sept 2011.
CONGESTIVE HEART FAILURE By: Sade Jordan Donisha Grier.
Heart Failure Whistle Stop Talks No. 2 Classification Implications Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
THE ROLE OF THE HEART FAILURE SPECIALIST NURSE NHS Grampian Heart Failure Nurses November 2008.
St Albans and Harpenden PCT Heart Failure Service Dr Kate Mackay Director of Public Health.
JONATHAN MANT, MD; ABDALLAH AL-MOHAMMAD, MD; SHARON SWAIN, BA, PHD; AND PHILIPPE LARAMEE,DC,MSC, FOR THE GUIDELINE DEVELOPMENT GROUP CHRIS FONTIMAYOR MS-III.
Heart Failure: From Failure to Success
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
The Nature of Disease.
Inequalities in coronary heart disease treatment Professor Azeem Majeed University College London.
Background, recognition and differentials. By Dr L Axten.
Locally Agreed Guidelines May Reduce Inappropriate Preoperative Echocardiography Requests Dr Sheila Carey Anaesthetic SpR Northern Deanery.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Heart Failure: a community-based diagnostic clinic & service
WHY THE CONCERN ABOUT ALCOHOL? AND WHAT DOES IT HAVE TO DO WITH GENERAL PRACTICE? Peter Rice, Consultant Psychiatrist, NHS Tayside.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
HEART FAILURE. Excellent Care 1. Diagnosis 2. ACE-I and B blocker 3. Aldosterone antagonist 4. Exercise 5. Statin and aspirin if CVD 6. Digoxin with AF.
How to make evidence based practice happen - Identifying the local priorities Dr David Walker NHS Improvement National Clinical Lead for Heart Failure.
Rapid assessment of chest pain Dr Phil Avery Prince Philip Hospital Hywel Dda Health Board PCCS 18 th May 2011.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
Adult Social Care and Health Select Committee Cancer in Nottingham Julie O’Boyle Specialty Registrar Public Health NHS Nottingham City Dr Chris Packham.
Dr Dylan Harris Dr Mel Jefferson
Chronic heart failure By Vishal Patel GPVTS1.
A Few Facts About Breast Cancer
Presentation transcript:

Heart Failure Diagnosis and Management in Primary Care Dr David Ebbs GP, Didcot Health Centre GPwSI Heart Failure, OxonPCT

What is heart failure? A clinical syndrome caused by a reduction in the hearts ability to pump blood around the body NSF, Chapter 6

ANY QUESTIONS?

Why is Heart Failure a priority? CHD NSF – Standard 11 NICE Guidelines SIGN 96 (2007) BJGP 2006;56:48-56/ 2007;57:180-1 JAMA 2008;299: nGMS Costs to NHS

NSF - Standard 11 –Doctors should arrange for people with suspected heart failure to be offered appropriate investigations (e.g. electrocardiography, echocardiography) that will confirm or refute the diagnosis. For those in whom heart failure is confirmed the cause should be identified and the treatments most likely to both relieve symptoms and reduce risk of death should be offered.

Heart failure Morbidity 5% all acute medical admissions (and 5% all deaths) 10 % all medical bed occupancy 2% total bed occupancy incl surgical beds 1 million inpatient bed days per year 50% HF in-patients readmitted within 3/12 of which 50% preventable Average HF admission £2500-NHS £716m/yr 1-2% total NHS spending, 60% of which on inpatient care Admissions expected to rise by 2% per year

Heart Failure Incidence % per year 2-3 new cases per list of 2000 Approx new HF diagnoses in Oxon per year

Heart Failure Prevalence % of population Very age dependant 10% in age >85 Approx cases per 2000 list

Heart Failure Presentation On GP population studies, only 35-40% of patients with clinical diagnosis of HF had LVSD on echo. So, 6-9 HF clinical presentations to get 2-3 patients with LVSD = Approx 2000 echocardiograms per year for new HF presentations in Oxfordshire

Evolution of Clinical Stages NORMAL Asymptomatic LV Dysfunction Asymptomatic LV Dysfunction Compensated HF Compensated HF Decompensated HF Decompensated HF No symptoms Normal exercise Normal LV fxn No symptoms Normal exercise Normal LV fxn No symptoms Normal exercise Abnormal LV fxn No symptoms Normal exercise Abnormal LV fxn No symptoms at rest Stairs(II) Flat(III) Abnormal LV fxn No symptoms at rest Stairs(II) Flat(III) Abnormal LV fxn Symptoms at rest Abnormal LV fxn Symptoms at rest Abnormal LV fxn Refractory HF Refractory HF NYHA I II III IV

Heart Failure Survival 50% of all patients with heart failure (all grades) die within 4 years Mean survival 3.2years for men and 5.4 years for women 5 year survival 25% for men and 38% for women 50% of those with grade IV die within 1 year Most common terminal illness

Heart Failure Survival One year survival rates, heart failure and the major cancers compared, mid-1990s, England and Wales NYHA IV

And yet……. 50% HF undiagnosed 50% of HF diagnosis incorrect 50% of correct diagnoses suboptimal Rx –<20% if consider Beta blockers optimal

Clinical diagnosis of HF 259 breathless pts presenting to GP; echo assessment of LV systolic function Davie et al. QJMed 1997:90; Sensitivity Specificity Dyspnoea100%17% Oedema49%47% Orthopnoea22%74% PND39%80% Oedema20%86% Crackles + oedema14%94% Displaced apex beat66%96% Displaced ab+other44%99% H/o MI59%86% H/o MI+any sign39%96% H/o MI +displaced apex beat 39%99%

Reasons for Poor Management? Concern re accessing and interpreting echocardiography Phenomenon of transient condition ie better after treatment and just continue Worries re polypharmacy Worries over safety of ACEI and B blockers in HF and other heart conditions Poor understanding and lack of confidence in HF management Reluctance in treating mild LVSD »

Pathophysiology LVSD / Myocardial damage Heart FailureLow stroke vol / cardiac output Neurohormonal response Sympathetic nerve activationRenin-angiotensin-aldosterone Vasoconstriction due to angiotensin II (and others) Sodium and fluid retention due to aldosterone Increased blood volume and further LVSD and heart failure

Causes of Heart Failure Critical to find cause as management depends on cause as much as to treat symptoms of HF Echo essential to find cause IHD 36% Hypertension 14% Arrhythmias / AF 30% Valvular 11% Cardiomyopathy 10% Others – Diastolic dysfunction, thyrotoxicosis, anaemia etc

Diagnosis History, commonly SOB, orthopnoea, PND, SOA, tired, poor exercise tolerance, muscle pain Examination – look for murmurs, creps/wheezes, oedema FBC, renal function, glucose, TSH, Lipids (if IHD) ECG CXR?? BNP?? And…

Echocardiography The gold standard Assesses LV function (35% have LVSD) Valves (antibiotic prophylaxis) Diastolic function Pericardial effusion Establishes aetiology of LVSD LV aneurysm and thrombus

Why is aetiology important? Guides most appropriate treatment IHD : treatment of HF plus IHD Valvular : medical and ? surgical Rx Diastolic dysfunction : different drugs No HF : ?stop drugs

Lv RV La Mv Av Ao

Lv La Mv Av Rv

Colour doppler

Endocardial thickening

Ejection fraction

Aortic stenosis

MV prolapse

Mitral stenosis

LV thrombus

Right heart

Pericardial effusion

Management of HF Aims : Reduce symptoms Increase quality of life Reduce progression of HF Reduce admissions (and hence overall costs)

Management of HF General Measures –Reduce weight –Increase fitness / exercise –Reduce salt and fluid intake –Smoking –Alcohol –vaccination

Management of HF Atlas Val-Heft Valiant Consensus CHARM – preserved CHARM – alternative CHARM – added Elite II Rales Solvd Comet VALUE SCOPE LIFE MERIT-HF CIBIS-II COPERNICUS BEST

NICE Management Algorithm New diagnosis Start ACEI (AIIA if ACEI intolerant) and titrate upwards Add Beta blocker and titrate upwards Add spironolactone if still symptomatic Seek specialist advice Add diuretic – likely to be required to control congestive sx and fluid retention Add digoxin – as first line if in AF – in addition if still symptomatic after diuretic, ACEI and beta blocker Generalist Specialist

Management of HF Loop diuretic first line in acute Pul oedema In confirmed LVSD, treat with ACEI (AIIA) to maximum dose (as tolerated by BP and renal function) In confirmed LVSD, even if asymptomatic, start and titrate cardioselective beta blocker If AF (any NYHA class) or still symptomatic, then add digoxin (consider anticoagulation also if AF) If still symptomatic, add spironolactone Stop negative inotropes (nifedipine, diltiazem) NSAIs, metformin etc

Monitoring Renal function and BP at each drug dose increment Patient weight self monitoring Patient held action plan Specialist Heart Failure nurses

Specialist management Investigation of ischaemia as cause for SOB Biventricular pacing Implantable defibs and assist devices Transplantation O2 and CPAP Specialist palliative care

Other aspects to consider Depression Pain (opiates) Fatigue Employment Driving Travel Palliative care

Diastolic LV Dysfunction Common in elderly and hypertensives. Also common in AF but no good echo markers. Management based around good BP control, with additional symptomatic relief using diuretics +/- oral nitrates as required. Due to poor relaxation of LV during diastole. Rate control also important. Controversial in HF circles. nGMS does not separate from LVSD

GPwSI – Heart Failure 2002 – one of several projects part of CHD Collaborative (NHS Modernisation agency) To establish community based heart failure diagnostic service PCT funded salaries Hardware purchased with one off capital grant

GPwSI – Heart Failure Myself and Peter Grimwade 2 sessions per week for 6+ years Training and service element Accreditation Ongoing supervision Clinics in Witney, Abingdon and Wallingford each week

Which Patients? Breathlessness with possible cardiac cause –Co-morbidities! Murmur assessments Cardiomegaly LVH on ECG AF-palpitations Family history

But NOT Acutely unwell Congenital heart disease Valve replacement Those under active cardiology follow up Rarities : amyloid, sarcoid, carcinoid, Marfans …..etc Children

Referral Form Faxed to Abingdon Sue Shipman F T Patient makes own appt ? Choice of locations DNA?

Referral form One stop opinion with benefit of echo Opinion may change in light of past history –IHD –DM –Hypertension Medication recommendations Other drugs or conditions eg COPD Results Renal function

What happens at the clinic Confirm history/examination Interpret data Echocardiogram Answer the question Patient information Onward referral for further investigations Report faxed Advice for referrer

What have we achieved? Local service – popular with patients Reduced cardiology OPD requests Good communications with referrers Improved treatment for some patients Accreditation A model that works

Thank you